• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
FDA

What’s Actually in Your Dietary Supplements? Maybe Drugs, Study Says

By
Brittany Shoot
Brittany Shoot
Down Arrow Button Icon
By
Brittany Shoot
Brittany Shoot
Down Arrow Button Icon
October 12, 2018, 7:21 PM ET

n wide-ranging analysis, researchers studying dietary supplements that had been submitted to the U.S. Food and Drug Administration (FDA) found that the little pills could be big trouble. Many of these unregulated, supposed dietary aids contain prescription drugs as part of their makeup, researchers wrote in an article published in the journal JAMA Network Open.

“Potentially harmful active pharmaceuticals continue to be identified in over-the-counter dietary supplements,” they wrote.

Looking at a period between 2007 and 2016, researchers analyzed supplements tainted with pharmaceuticals. In those years, they found that one in five dietary supplements contained more than one drug ingredient. During that period, 776 supplements marketed for muscle building, sexual enhancement, or weight loss were found to contain prescription drugs, such as the stimulant ephedrine, anabolic steroids, and selective serotonin reuptake inhibitors (SSRIs) commonly prescribed to treat anxiety and depression, as well as the active ingredients in erectile dysfunction drugs Viagra and Cialis, to name a few.

That isn’t a minor complication. These types of contaminations can have severe or even fatal implications for patients living with conditions such as heart disease or high cholesterol, which require medical oversight to stay healthy. Pop a pill that contains a drug that lowers your blood pressure, and if you happen to suffer from low blood pressure already, the consequences of this lack of oversight could be dire. Multiply that across most major types of managed conditions, and you can start to understand the severity of what researchers uncovered.

What’s possibly more alarming about the study, researchers say that even though these compromised supplements were submitted to the agency, the FDA often didn’t recall the tainted products, allowing them to remain on the market—and many are still on the market now.

In a commentary accompanying the article, Harvard Medical School professor and general internist Dr. Pieter A. Cohen chastised the FDA for a “dereliction of duty” as the agency responsible for regulating and ensuring the safety of consumer dietary supplements such as vitamins, minerals, probiotics, amino acids, and enzymes.

“While the FDA does not assess the safety of supplements prior to market, the agency is tasked with identifying and removing adulterated and hazardous supplements from the marketplace,” he wrote. “The FDA didn’t even bother to recall more than half of the potentially hazardous supplements.”

Dietary supplements are big business, a $35 billion industry in the United States alone. There are more than 90,000 vitamin and mineral supplements on the market, according to an article in JAMA, the Journal of the American Medical Association.

At least 52% of American adults take at least one dietary supplement every day, and 10% take at least four. Vitamins and minerals are the most popular supplement types, many with benefits advertised to maintain health and prevent disease. It remains unclear how effective these supplements, such as Vitamin D, the subject of a recent study, are to an individual’s long-term health.

About the Author
By Brittany Shoot
See full bioRight Arrow Button Icon

Latest in

Five panelists seated; two women and five men.
AIBrainstorm AI
The race to deploy an AI workforce faces one important trust gap: What happens when an agent goes rogue?
By Amanda GerutDecember 11, 2025
50 minutes ago
Stephanie Zhan, Partner Sequoia Capital speaking on stage at Fortune Brainstorm AI San Francisco 2025.
AIEye on AI
Highlights from Fortune Brainstorm AI San Francisco
By Jeremy KahnDecember 11, 2025
1 hour ago
Sam Altman
Arts & EntertainmentMedia
‘We’re not just going to want to be fed AI slop for 16 hours a day’: Analyst sees Disney/OpenAI deal as a dividing line in entertainment history
By Nick LichtenbergDecember 11, 2025
1 hour ago
InnovationBrainstorm AI
Backflips are easy, stairs are hard: Robots still struggle with simple human movements, experts say
By Nicholas GordonDecember 11, 2025
2 hours ago
Personal FinanceLoans
Is it worth it to pay off a personal loan early?
By Joseph HostetlerDecember 11, 2025
2 hours ago
Iger
AIDisney
‘Creativity is the new productivity’: Bob Iger on why Disney chose to be ‘aggressive,’ adding OpenAI as a $1 billion partner
By Nick LichtenbergDecember 11, 2025
4 hours ago

Most Popular

placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
2 days ago
placeholder alt text
Economy
‘Be careful what you wish for’: Top economist warns any additional interest rate cuts after today would signal the economy is slipping into danger
By Eva RoytburgDecember 10, 2025
1 day ago
placeholder alt text
Politics
Exclusive: U.S. businesses are getting throttled by the drop in tourism from Canada: ‘I can count the number of Canadian visitors on one hand’
By Dave SmithDecember 10, 2025
1 day ago
placeholder alt text
Investing
Baby boomers have now 'gobbled up' nearly one-third of America's wealth share, and they're leaving Gen Z and millennials behind
By Sasha RogelbergDecember 8, 2025
3 days ago
placeholder alt text
Success
Netflix–Paramount bidding wars are pushing Warner Bros CEO David Zaslav toward billionaire status—he has one rule for success: ‘Never be outworked’
By Preston ForeDecember 10, 2025
1 day ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
15 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.